Cancer therapies specifically targeting FAP are still in their early phases, with several strategies being explored, such as FAP-targeted antibodies and small molecule inhibitors, vaccine therapy, and CAR T-cell therapy (NCT03932565) [7–12]. The gene discussed is FAP; the disease is cancer.